Insider Monkey
Orexin-2 Receptor Data Reinforces a Positive Outlook for Centessa (CNTA)
📈
AI Sentiment
Highly Positive
9/10
Centessa Pharmaceuticals plc News
Latest updates and market news for CNTA
3 news
Feb 13 - Feb 19, 2026
Page 1
Simply Wall St.
Centessa Pharmaceuticals (CNTA) Valuation Check After Recent Share Price Strength
📊
AI Sentiment
Positive
6/10
MarketBeat
Centessa Pharmaceuticals CEO Teases “Transformational” 2026 as ORX750 Nears Registrational Trials
📈
AI Sentiment
Highly Positive
9/10
Share this news page